Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Fibromyalgia HELP
Based on 3,739 articles published since 2009
||||

These are the 3739 published articles about Fibromyalgia that originated from Worldwide during 2009-2019.
 
+ Citations + Abstracts
Pages: 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · 11 · 12 · 13 · 14 · 15 · 16 · 17 · 18 · 19 · 20
1 Guideline New guidelines for the diagnosis of fibromyalgia. 2017

Heymann, Roberto E / Paiva, Eduardo S / Martinez, José Eduardo / Helfenstein, Milton / Rezende, Marcelo C / Provenza, Jose Roberto / Ranzolin, Aline / Assis, Marcos Renato de / Feldman, Daniel P / Ribeiro, Luiz Severiano / Souza, Eduardo J R. ·Sociedade Brasileira de Reumatologia, Brazil; Universidade Federal do Estado de São Paulo, São Paulo, SP, Brazil. Electronic address: roberto.heymann@gmail.com. · Sociedade Brasileira de Reumatologia, Brazil; Universidade Federal do Paraná, Curitiba, PR, Brazil. · Sociedade Brasileira de Reumatologia, Brazil; Pontifícia Universidade Católica de São Paulo, Sorocaba, SP, Brazil. · Sociedade Brasileira de Reumatologia, Brazil; Universidade Federal do Estado de São Paulo, São Paulo, SP, Brazil. · Sociedade Brasileira de Reumatologia, Brazil; Santa Casa de Campo Grande, Campo Grande, MS, Brazil. · Sociedade Brasileira de Reumatologia, Brazil; Pontifícia Universidade Católica de Campinas, Campinas, SP, Brazil. · Sociedade Brasileira de Reumatologia, Brazil; Hospital das Clínicas de Pernambuco, Recife, PE, Brazil. · Sociedade Brasileira de Reumatologia, Brazil; Faculdade de Medicina de Marília, Marília, SP, Brazil. · Sociedade Brasileira de Reumatologia, Brazil; Hospital do Servidor Público de Minas Gerais, Belo Horizonte, MG, Brazil. · Sociedade Brasileira de Reumatologia, Brazil; Santa Casa de Belo Horizonte, Belo Horizonte, MG, Brazil. ·Rev Bras Reumatol Engl Ed · Pubmed #28800969.

ABSTRACT: OBJECTIVE: To establish guidelines based on scientific evidence for the diagnosis of fibromyalgia. MATERIAL AND METHODS: Evidence collection was performed based on 9 questions regarding the diagnosis of fibromyalgia, structured using the Patient, Intervention or Indicator, Comparison and Outcome (P.I.C.O.), with searches in the main, primary databases of scientific information. After defining the potential studies to support the recommendations, they were graded according to evidence and degree of recommendation.

2 Guideline [Guidelines for the diagnosis and treatment of the fibromyalgia syndrome]. 2013

Ablin, Jacob N / Amital, Howard / Ehrenfeld, Michael / Aloush, Valerie / Elkayam, Ori / Langevitz, Pnina / Mevorach, Dror / Mader, Reuven / Sachar, Tali / Amital, Daniela / Buskila, Dan / Anonymous3730783. ·Institute of Rheumatotogy, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv, Israel. · Department of Medicine B, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Zabludowicz Center for Autoimmune Diseases, Chaim Sheba Medical Center, Tel-Hashomer and Sackler Faculty of Medicine, Tel Aviv University, Israel. · Rheumatalogy Unit, Sheba Medical Center, Tel-Hashomer, the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · The Laboratory for Cevlular and Molecular Immunology, Department of Medicine, Rheumatology Research Center, Hadassah-Hebrew University Medical Center, Jerusalem. Israel. · Rheumatic Diseases Unit, Ha'Emek Medical Center, Afula, Israel. · Family Medicine Department, Hebrew University, Jerusalem, Israel. · Department of Psychiatry 'B, Ness Ziona Mental Health Center, Ness Ziona, Israel and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Department of Medicine H, Soroka Medical Center and Faculty of Health Sciences, Ben Gurion University, Beer Sheva, Israel. ·Harefuah · Pubmed #24483001.

ABSTRACT: Over the past years, considerable progress has been made in understanding the pathogenesis of the fibromyatgia syndrome and the evidence based approach to the diagnosis and management has been significantty extended. The purpose of the current project is to develop practicat and evidence based guidetine recommendations for the Israeli health care system. A panet of physicians with clinical and research experience in the fibromyalgia field was convened under the auspices of the Israeli Rheumatology Association. A systematic review was performed on the current literature regarding the diagnosis and treatment of fibromyalgia. Using an interactive discussion procedure, recommendations were reached and expert opinion was introduced where evidence was considered incomplete. The panel recommendations underline the importance of concomitant and integrated medical therapy, such as serotonin and noradrenaline reuptake inhibitor (SNRI) anti-depressants or gamma-aminobutyric acid (GABA) related anti-epileptics, with regular aerobic physical exercise.

3 Guideline 2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary. 2013

Fitzcharles, Mary-Ann / Ste-Marie, Peter A / Goldenberg, Don L / Pereira, John X / Abbey, Susan / Choinière, Manon / Ko, Gordon / Moulin, Dwight E / Panopalis, Pantelis / Proulx, Johanne / Shir, Yoram / Anonymous6591223. ·Division of Rheumatology, McGill University Health Centre, Montreal, Quebec, Canada. mary-ann.fitzcharles@muhc.mcgill.ca ·Pain Res Manag · Pubmed #23748251.

ABSTRACT: BACKGROUND: Recent neurophysiological evidence attests to the validity of fibromyalgia (FM), a chronic pain condition that affects >2% of the population. OBJECTIVES: To present the evidence-based guidelines for the diagnosis, management and patient trajectory of individuals with FM. METHODS: A needs assessment following consultation with diverse health care professionals identified questions pertinent to various aspects of FM. A literature search identified the evidence available to address these questions; evidence was graded according to the standards of the Oxford Centre for Evidence-Based Medicine. Drafted recommendations were appraised by an advisory panel to reflect meaningful clinical practice. RESULTS: The present recommendations incorporate the new clinical concepts of FM as a clinical construct without any defining physical abnormality or biological marker, characterized by fluctuating, diffuse body pain and the frequent symptoms of sleep disturbance, fatigue, mood and cognitive changes. In the absence of a defining cause or cure, treatment objectives should be patient-tailored and symptom-based, aimed at reducing global complaints and enhancing function. Healthy lifestyle practices with active patient participation in health care forms the cornerstone of care. Multimodal management may include nonpharmacological and pharmacological strategies, although it must be acknowledged that pharmacological treatments provide only modest benefit. Maintenance of function and retention in the workforce is encouraged. CONCLUSIONS: The new Canadian guidelines for the treatment of FM should provide health professionals with confidence in the complete care of these patients and improve clinical outcomes.

4 Guideline [Definition, diagnosis and therapy of chronic widespread pain and so-called fibromyalgia syndrome in children and adolescents. Systematic literature review and guideline]. 2012

Zernikow, B / Gerhold, K / Bürk, G / Häuser, W / Hinze, C H / Hospach, T / Illhardt, A / Mönkemöller, K / Richter, M / Schnöbel-Müller, E / Häfner, R / Anonymous10160730. ·Deutsches Kinderschmerzzentrum, Vestische Kinder- und Jugendklinik, Universität Witten/Herdecke, Dr.-Friedrich-Steiner-Str. 5, 45711, Datteln, Deutschland. b.zernikow@deutsches-kinderschmerzzentrum.de ·Schmerz · Pubmed #22760465.

ABSTRACT: BACKGROUND: The scheduled update to the German S3 guidelines on fibromyalgia syndrome (FMS) by the Association of the Scientific Medical Societies ("Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften", AWMF; registration number 041/004) was planned starting in March 2011. MATERIALS AND METHODS: The development of the guidelines was coordinated by the German Interdisciplinary Association for Pain Therapy ("Deutsche Interdisziplinären Vereinigung für Schmerztherapie", DIVS), 9 scientific medical societies and 2 patient self-help organizations. Eight working groups with a total of 50 members were evenly balanced in terms of gender, medical field, potential conflicts of interest and hierarchical position in the medical and scientific fields. Literature searches were performed using the Medline, PsycInfo, Scopus and Cochrane Library databases (until December 2010). The grading of the strength of the evidence followed the scheme of the Oxford Centre for Evidence-Based Medicine. The formulation and grading of recommendations was accomplished using a multi-step, formal consensus process. The guidelines were reviewed by the boards of the participating scientific medical societies. RESULTS AND CONCLUSION: The diagnosis FMS in children and adolescents is not established. In so-called juvenile FMS (JFMS) multidimensional diagnostics with validated measures should be performed. Multimodal therapy is warranted. In the case of severe pain-related disability, therapy should be primarily performed on an inpatient basis. The English full-text version of this article is available at SpringerLink (under "Supplemental").

5 Guideline [Complementary and alternative therapies for fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. 2012

Langhorst, J / Häuser, W / Bernardy, K / Lucius, H / Settan, M / Winkelmann, A / Musial, F / Anonymous10140730. ·Innere Medizin V (Naturheilkunde und Integrative Medizin), Kliniken Essen-Mitte, Am Deimelsberg 34a, 45276, Essen, Deutschland. j.langhorst@kliniken-essen-mitte.de ·Schmerz · Pubmed #22760464.

ABSTRACT: BACKGROUND: The scheduled update to the German S3 guidelines on fibromyalgia syndrome (FMS) by the Association of the Scientific Medical Societies ("Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften", AWMF; registration number 041/004) was planned starting in March 2011. MATERIALS AND METHODS: The development of the guidelines was coordinated by the German Interdisciplinary Association for Pain Therapy ("Deutsche Interdisziplinären Vereinigung für Schmerztherapie", DIVS), 9 scientific medical societies and 2 patient self-help organizations. Eight working groups with a total of 50 members were evenly balanced in terms of gender, medical field, potential conflicts of interest and hierarchical position in the medical and scientific fields. Literature searches were performed using the Medline, PsycInfo, Scopus and Cochrane Library databases (until December 2010). The grading of the strength of the evidence followed the scheme of the Oxford Centre for Evidence-Based Medicine. The recommendations were based on level of evidence, efficacy (meta-analysis of the outcomes pain, sleep, fatigue and health-related quality of life), acceptability (total dropout rate), risks (adverse events) and applicability of treatment modalities in the German health care system. The formulation and grading of recommendations was accomplished using a multi-step, formal consensus process. The guidelines were reviewed by the boards of the participating scientific medical societies. RESULTS AND CONCLUSION: Meditative movement therapies (qi gong, tai chi, yoga) are strongly recommended. Acupuncture can be considered. Mindfulness-based stress reduction as monotherapy and dance therapy as monotherapy are not recommended. Homeopathy is not recommended. In a minority vote, homeopathy was rated as "can be considered". Nutritional supplements and reiki are not recommended. The English full-text version of this article is available at SpringerLink (under "Supplemental").

6 Guideline [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. 2012

Sommer, C / Häuser, W / Alten, R / Petzke, F / Späth, M / Tölle, T / Uçeyler, N / Winkelmann, A / Winter, E / Bär, K J / Anonymous10150730. ·Neurologische Klinik, Universitätsklinikum Würzburg, Josef-Schneider-Str. 11, 97080, Würzburg, Deutschland. sommer@uni-wuerzburg.de ·Schmerz · Pubmed #22760463.

ABSTRACT: BACKGROUND: The scheduled update to the German S3 guidelines on fibromyalgia syndrome (FMS) by the Association of the Scientific Medical Societies ("Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften", AWMF; registration number 041/004) was planned starting in March 2011. MATERIALS AND METHODS: The development of the guidelines was coordinated by the German Interdisciplinary Association for Pain Therapy ("Deutsche Interdisziplinären Vereinigung für Schmerztherapie", DIVS), 9 scientific medical societies and 2 patient self-help organizations. Eight working groups with a total of 50 members were evenly balanced in terms of gender, medical field, potential conflicts of interest and hierarchical position in the medical and scientific fields. Literature searches were performed using the Medline, PsycInfo, Scopus and Cochrane Library databases (until December 2010). The grading of the strength of the evidence followed the scheme of the Oxford Centre for Evidence-Based Medicine. The recommendations were based on level of evidence, efficacy (meta-analysis of the outcomes pain, sleep, fatigue and health-related quality of life), acceptability (total dropout rate), risks (adverse events) and applicability of treatment modalities in the German health care system. The formulation and grading of recommendations was accomplished using a multi-step, formal consensus process. The guidelines were reviewed by the boards of the participating scientific medical societies. RESULTS AND CONCLUSION: Amitriptyline and-in case of comorbid depressive disorder or generalized anxiety disorder-duloxetine are recommended. Off-label use of duloxetine and pregabalin can be considered in case of no comorbid mental disorder. Strong opioids are not recommended. The English full-text version of this article is available at SpringerLink (under "Supplemental").

7 Guideline [Psychotherapy for patients with fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. 2012

Köllner, V / Häuser, W / Klimczyk, K / Kühn-Becker, H / Settan, M / Weigl, M / Bernardy, K / Anonymous10130730. ·Fachklinik für Psychosomatische Medizin, MediClin Bliestal Kliniken, Am Spitzenberg, 66440, Blieskastel, Deutschland. volker.koellner@mediclin.de ·Schmerz · Pubmed #22760462.

ABSTRACT: BACKGROUND: The scheduled update to the German S3 guidelines on fibromyalgia syndrome (FMS) by the Association of the Scientific Medical Societies ("Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften", AWMF; registration number 041/004) was planned starting in March 2011. MATERIALS AND METHODS: The development of the guidelines was coordinated by the German Interdisciplinary Association for Pain Therapy ("Deutsche Interdisziplinären Vereinigung für Schmerztherapie", DIVS), 9 scientific medical societies and 2 patient self-help organizations. Eight working groups with a total of 50 members were evenly balanced in terms of gender, medical field, potential conflicts of interest and hierarchical position in the medical and scientific fields. Literature searches were performed using the Medline, PsycInfo, Scopus and Cochrane Library databases (until December 2010). The grading of the strength of the evidence followed the scheme of the Oxford Centre for Evidence-Based Medicine. The recommendations were based on level of evidence, efficacy (meta-analysis of the outcomes pain, sleep, fatigue and health-related quality of life), acceptability (total dropout rate), risks (adverse events) and applicability of treatment modalities in the German health care system. The formulation and grading of recommendations was accomplished using a multi-step, formal consensus process. The guidelines were reviewed by the boards of the participating scientific medical societies. RESULTS AND CONCLUSION: Cognitive behavioral therapy combined with aerobic exercise (multicomponent therapy) is strongly recommended. Relaxation as single therapy should not be applied. The English full-text version of this article is available at SpringerLink (under "Supplemental").

8 Guideline [Multicomponent therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. 2012

Arnold, B / Häuser, W / Arnold, M / Bernateck, M / Bernardy, K / Brückle, W / Friedel, E / Hesselschwerdt, H J / Jäckel, W / Köllner, V / Kühn, E / Petzke, F / Settan, M / Weigl, M / Winter, E / Offenbächer, M / Anonymous10110730. ·Abteilung für Schmerztherapie, Klinikum Dachau, Krankenhausstr. 15, 85221, Dachau, Deutschland. bernhard.arnold@amperkliniken.de ·Schmerz · Pubmed #22760461.

ABSTRACT: BACKGROUND: The scheduled update to the German S3 guidelines on fibromyalgia syndrome (FMS) by the Association of the Scientific Medical Societies ("Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften", AWMF; registration number 041/004) was planned starting in March 2011. MATERIALS AND METHODS: The development of the guidelines was coordinated by the German Interdisciplinary Association for Pain Therapy ("Deutsche Interdisziplinären Vereinigung für Schmerztherapie", DIVS), 9 scientific medical societies and 2 patient self-help organizations. Eight working groups with a total of 50 members were evenly balanced in terms of gender, medical field, potential conflicts of interest and hierarchical position in the medical and scientific fields. Literature searches were performed using the Medline, PsycInfo, Scopus and Cochrane Library databases (until December 2010). The grading of the strength of the evidence followed the scheme of the Oxford Centre for Evidence-Based Medicine. The formulation and grading of recommendations was accomplished using a multi-step, formal consensus process. The guidelines were reviewed by the boards of the participating scientific medical societies. RESULTS AND CONCLUSION: The use of a multicomponent therapy (the combination of aerobic exercise with at least one psychological therapy) for a minimum of 24 h is strongly recommended for patients with severe FMS. The English full-text version of this article is available at SpringerLink (under "Supplemental").

9 Guideline [Physiotherapy and physical therapies for fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. 2012

Winkelmann, A / Häuser, W / Friedel, E / Moog-Egan, M / Seeger, D / Settan, M / Weiss, T / Schiltenwolf, M / Anonymous10120730. ·Klinik und Poliklinik für Physikalische Medizin und Rehabilitation, Klinikum der Universität München, Ziemssenstr. 1, 80336, München, Deutschland. andreas.winkelmann@med.uni-muenchen.de ·Schmerz · Pubmed #22760460.

ABSTRACT: BACKGROUND: The scheduled update to the German S3 guidelines on fibromyalgia syndrome (FMS) by the Association of the Scientific Medical Societies ("Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften", AWMF; registration number 041/004) was planned starting in March 2011. MATERIALS AND METHODS: The development of the guidelines was coordinated by the German Interdisciplinary Association for Pain Therapy ("Deutsche Interdisziplinären Vereinigung für Schmerztherapie", DIVS), 9 scientific medical societies and 2 patient self-help organizations. Eight working groups with a total of 50 members were evenly balanced in terms of gender, medical field, potential conflicts of interest and hierarchical position in the medical and scientific fields. Literature searches were performed using the Medline, PsycInfo, Scopus and Cochrane Library databases (until December 2010). The grading of the strength of the evidence followed the scheme of the Oxford Centre for Evidence-Based Medicine. The formulation and grading of recommendations was accomplished using a multi-step, formal consensus process. The guidelines were reviewed by the boards of the participating scientific medical societies. RESULTS AND CONCLUSION: Low-to-moderate intensity aerobic exercise and strength training are strongly recommended. Chiropractic, laser therapy, magnetic field therapy, massage and transcranial current stimulation are not recommended. The English full-text version of this article is available at SpringerLink (under "Supplemental").

10 Guideline [Fibromyalgia syndrome. General principles and coordination of clinical care and patient education]. 2012

Eich, W / Häuser, W / Arnold, B / Bernardy, K / Brückle, W / Eidmann, U / Klimczyk, K / Köllner, V / Kühn-Becker, H / Offenbächer, M / Settan, M / von Wachter, M / Petzke, F / Anonymous10100730. ·Klinik für Allgemeine Innere Medizin und Psychosomatik, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 10, 69210, Heidelberg, Deutschland. wolfgang.eich@med.uni-heidelberg.de ·Schmerz · Pubmed #22760459.

ABSTRACT: BACKGROUND: The scheduled update to the German S3 guidelines on fibromyalgia syndrome (FMS) by the Association of the Scientific Medical Societies ("Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften", AWMF; registration number 041/004) was planned starting in March 2011. MATERIALS AND METHODS: The development of the guidelines was coordinated by the German Interdisciplinary Association for Pain Therapy ("Deutsche Interdisziplinären Vereinigung für Schmerztherapie", DIVS), 9 scientific medical societies and 2 patient self-help organizations. Eight working groups with a total of 50 members were evenly balanced in terms of gender, medical field, potential conflicts of interest and hierarchical position in the medical and scientific fields. Literature searches were performed using the Medline, PsycInfo, Scopus and Cochrane Library databases (until December 2010). The grading of the strength of the evidence followed the scheme of the Oxford Centre for Evidence-Based Medicine. The formulation and grading of recommendations was accomplished using a multi-step, formal consensus process. The guidelines were reviewed by the boards of the participating scientific medical societies. RESULTS AND CONCLUSION: A diagnosis of FMS should be explicitly communicated with the afflicted individual. A step-wise treatment, depending on the severity of FMS and the responses to therapeutic measures, is recommended. Therapy should only be continued if the positive effects outweigh the side effects. The English full-text version of this article is available at SpringerLink (under "Supplemental").

11 Guideline [Etiology and pathophysiology of fibromyalgia syndrome]. 2012

Sommer, C / Häuser, W / Burgmer, M / Engelhardt, R / Gerhold, K / Petzke, F / Schmidt-Wilcke, T / Späth, M / Tölle, T / Uçeyler, N / Wang, H / Winkelmann, A / Thieme, K / Anonymous10080730. ·Neurologische Klinik, Universitätsklinikum Würzburg, Josef-Schneider-Str. 11, 97080, Würzburg, Deutschland. sommer@uni-wuerzburg.de ·Schmerz · Pubmed #22760458.

ABSTRACT: BACKGROUND: The scheduled update to the German S3 guidelines on fibromyalgia syndrome (FMS) by the Association of the Scientific Medical Societies ("Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften", AWMF; registration number 041/004) was planned starting in March 2011. MATERIALS AND METHODS: The development of the guidelines was coordinated by the German Interdisciplinary Association for Pain Therapy ("Deutsche Interdisziplinären Vereinigung für Schmerztherapie", DIVS), 9 scientific medical societies and 2 patient self-help organizations. Eight working groups with a total of 50 members were evenly balanced in terms of gender, medical field, potential conflicts of interest and hierarchical position in the medical and scientific fields. Literature searches were performed using the Medline, PsycInfo, Scopus and Cochrane Library databases (until December 2010). The grading of the strength of the evidence followed the scheme of the Oxford Centre for Evidence-Based Medicine. RESULTS: Current data do not identify distinct etiologic or pathophysiological factors mediating development of FMS. The development of FMS is associated with inflammatory rheumatic diseases (EL2b), with gene polymorphisms of the 5-hydroxytryptamine (HT)(2) receptor (EL3a), lifestyle factors (smoking, obesity, lack of physical activity; EL2b), physical and sexual abuse in childhood and adulthood (EL3a). CONCLUSION: FMS is most likely the result of various pathogenetic factors and pathophysiological mechanisms. The English full-text version of this article is available at SpringerLink (under "Supplemental").

12 Guideline [Fibromyalgia syndrome. Definition, classification, clinical diagnosis and prognosis]. 2012

Eich, W / Häuser, W / Arnold, B / Jäckel, W / Offenbächer, M / Petzke, F / Schiltenwolf, M / Settan, M / Sommer, C / Tölle, T / Uçeyler, N / Henningsen, P / Anonymous10090730. ·Klinik für Allgemeine Innere Medizin und Psychosomatik, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 10, 69210, Heidelberg, Deutschland. wolfgang.eich@med.uni-heidelberg.de ·Schmerz · Pubmed #22760457.

ABSTRACT: BACKGROUND: The scheduled update to the German S3 guidelines on fibromyalgia syndrome (FMS) by the Association of the Scientific Medical Societies ("Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften", AWMF; registration number 041/004) was planned starting in March 2011. MATERIALS AND METHODS: The development of the guidelines was coordinated by the German Interdisciplinary Association for Pain Therapy ("Deutsche Interdisziplinären Vereinigung für Schmerztherapie", DIVS), 9 scientific medical societies and 2 patient self-help organizations. Eight working groups with a total of 50 members were evenly balanced in terms of gender, medical field, potential conflicts of interest and hierarchical position in the medical and scientific fields. Literature searches were performed using the Medline, PsycInfo, Scopus and Cochrane Library databases (until December 2010). The grading of the strength of the evidence followed the scheme of the Oxford Centre for Evidence-Based Medicine. The formulation and grading of recommendations was accomplished using a multi-step, formal consensus process. The guidelines were reviewed by the boards of the participating scientific medical societies. RESULTS AND CONCLUSION: The clinical diagnosis of FMS can be established by the American College of Rheumatology (ACR) 1990 classification criteria (with tender point examination), by the modified preliminary diagnostic ACR 2010 criteria or by the diagnostic criteria of the German interdisciplinary guideline (AWMF) on FMS. The English full-text version of this article is available at SpringerLink (under "Supplemental").

13 Guideline Interdisciplinary consensus document for the treatment of fibromyalgia. 2010

de Miquel, C Alegre / Campayo, J García / Flórez, M Tomás / Arguelles, J M Gómez / Tarrio, E Blanco / Montoya, M Gobbo / Martin, Á Pérez / Salio, A Martínez / Fuentes, J Vidal / Alberch, E Altarriba / de la Cámara, A Gómez. ·Jefe de Servicio de ReumatologíaHospital Universitari Val d’HebrónBarcelona, Spain. ·Actas Esp Psiquiatr · Pubmed #21361054.

ABSTRACT: Backgrounds. The elevated prevalence and enormous clinical and social impact of fibromyalgia, together with the complexity of its treatment, require action consensuses that guide health care professionals. Although there are some similar documents in our language, most have been made from the perspective of a single discipline.Objective. To develop a consensus on the treatment of fibromyalgia made by selected representatives and supported by the principal medical associations that intervene in its treatment (rheumatology, neurology, psychiatry,rehabilitation and family medicine) and representatives of the associations of patients. On the other hand, understanding the disease not as a homogenous disorders but also as the sum of different clinical subtypes,having specific symptomatic characteristics and different therapeutic needs is stressed. This approach represented a need perceived by the clinicians and a novelty regarding previous consensuses.Methods. The different clinical classifications proposed in fibromyalgia and the scientific evidence of the treatments used in this disease were reviewed. For the selection of the classification used and performance of the therapeutic recommendations, some of the usual techniques to obtain the consensus (nominal group and brainstorming) were used.Conclusion. The classification of Giesecke of fibromyalgia into 3 subgroups seems to have the greatest scientific evidence and the most useful for the clinician. The guide offers a series of general recommendations for all the patients with fibromyalgia. However, in addition, for each subgroup, there are a series of specific pharmacological and psychological-type recommendations and those of modification of the environment, which will make it possible to have a personalized approach to the patient with fibromyalgia in accordance with their individual clinical characteristics (pain, catastrophizing levels, etc.).

14 Editorial The role of patient organisation in fibromyalgia and related syndromes. 2019

Gur, Sharon / Ablin, Jacob N. ·Department of Internal Medicine H, Tel Aviv Sourasky Medical Centre, Israel. · Department of Internal Medicine H, Tel Aviv Sourasky Medical Centre, Israel. kobby.ablin@gmail.com. ·Clin Exp Rheumatol · Pubmed #30747095.

ABSTRACT:

15 Editorial [A weakly negative recommendation is not an absolute "no" : Comment on AWMF guideline recommendations for cannabis-based medicines in fibromyalgia syndrome]. 2018

Häuser, W / Petzke, F / Nothacker, M. ·Innere Medizin 1, Klinikum Saarbrücken GmbH, Winterberg 1, 66119, Saarbrücken, Deutschland. whaeuser@klinikum-saarbruecken.de. · MVZ für Schmerzmedizin und seelische Gesundheit Saarbrücken St. Johann, 66111, Saarbrücken, Deutschland. whaeuser@klinikum-saarbruecken.de. · Schmerzmedizin, Klinik für Anästhesiologie, Universitätsmedizin Göttingen, 37075, Göttingen, Deutschland. · AWMF-Geschäftsstelle, Berlin, Deutschland. ·Schmerz · Pubmed #30259150.

ABSTRACT: -- No abstract --

16 Editorial Fibromyalgia and small-fiber polyneuropathy: What's in a name? 2018

Farhad, Khosro / Oaklander, Anne Louise. ·Nerve unit, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, 275 Charles Street, Warren 801, Boston, Massachusetts, 02114, USA. · Department of Neurology, Wentworth-Douglass Hospital, Dover, New Hampshire, USA. · Department of Pathology (Neuropathology), Massachusetts General Hospital, Boston, Massachusetts, USA. ·Muscle Nerve · Pubmed #29938813.

ABSTRACT: -- No abstract --

17 Editorial Benefits of Tai Chi for fibromyalgia. 2018

Sawynok, Jana. ·Departments of Pharmacology, Anesthesia, Perioperative Medicine & Pain Management, Dalhousie University, Halifax, Nova Scotia, Canada. ·Pain Manag · Pubmed #29869558.

ABSTRACT: -- No abstract --

18 Editorial Editorial: Functional Connectivity: Dissecting the Relationship Between the Brain and "Pain Centralization" in Rheumatoid Arthritis. 2018

Lee, Yvonne C / Napadow, Vitaly / Loggia, Marco L. ·Northwestern University Feinberg School of Medicine, Chicago, Illinois. · Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts. ·Arthritis Rheumatol · Pubmed #29761844.

ABSTRACT: -- No abstract --

19 Editorial Low-grade chronic inflammation mediated by mast cells in fibromyalgia: role of IL-37. 2018

Mastrangelo, F / Frydas, I / Ronconi, G / Kritas, S K / Tettamanti, L / Caraffa, Al / D Ovidio, C / Younes, A / Gallenga, C E / Conti, P. ·Department of Medical Science and Biotechnology, University of Foggia, Foggia, Italy. · Faculty of Parasitology, Aristotle University of Thessaloniki, Macedonia, Greece. · UOS Clinica dei Pazienti del Territorio, Policlinico Gemelli, Rome, Italy. · Department of Microbiology and Infectious Diseases, Aristotle University of Thessaloniki, Macedonia, Greece. · Department of Medical and Morphological Science, University of Insubria, Varese, Italy. · Department of Pharmacology, University of Perugia, Perugia, Italy. · Section of Legal Medicine, Department of Medicine and Aging Sciences, University of Chieti-Pescara, Chieti, Italy. · Department of Anesthesiology, ‘Santo Spirito’ Hospital, Pescara, Italy. · Department of Biomedical Sciences and Specialist Surgery, Section of Ophthalmology, University of Ferrara, Italy. · Immunology Division, Postgraduate Medical School, University of Chieti-Pescara, Chieti, Italy. ·J Biol Regul Homeost Agents · Pubmed #29684996.

ABSTRACT: It has been observed that acute stress causes the activation of TH1 cells, while TH2 cells regulate and act on chronic inflammation. Fibromyalgia (FM) is a chronic, idiopathic disorder which affects about twelve million people in the United States. FM is characterized by chronic widespread pain, fatigue, aching, joint stiffness, depression, cognitive dysfunction and non-restorative sleep. The mechanism of induction of muscle pain and inflammation is not yet clear. In FM there is an increase in reactivity of central neurons with increased sensitivity localized mainly in the CNS. Mast cells are involved in FM by releasing proinflammatory cytokines, chemokines, chemical mediators, and PGD2. TNF is a cytokine generated by MCs and its level is higher in FM. The inhibition of pro-inflammatory IL-1 family members and TNF by IL-37 in FM could have a therapeutic effect. Here, we report for the first time the relationship between MCs, inflammatory cytokines and the new anti-inflammatory cytokine IL-37 in FM.

20 Editorial [Fibromyalgia as a paradigm of outstanding challenges in primary care]. 2017

Martín Sánchez, V. ·Editor Jefe, SEMERGEN-Medicina de Familia. Electronic address: vicente.martin@unileon.es. ·Semergen · Pubmed #28958383.

ABSTRACT: -- No abstract --

21 Editorial Another Nasty Effect of Opioids: Attenuating the Benefits of Motivational Interviewing in Fibromyalgia? 2017

Fitzcharles, Mary-Ann / Shir, Yoram. ·Alan Edwards Pain Management Unit, McGill University Health Centre, and Division of Rheumatology, McGill University; mary-ann.fitzcharles@muhc.mcgill.ca. · Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, Quebec, Canada. ·J Rheumatol · Pubmed #28604346.

ABSTRACT: -- No abstract --

22 Editorial [Twelve years of the S3 guideline Fibromyalgia Syndrome-a never-ending war?] 2017

Häuser, W / Kühn, E / Wolf, B / Nothacker, M / Petzke, F. ·Klinik Innere Medizin I (Gastroenterologie, Hepatologie, Stoffwechsel- und Infektionskrankheiten, Psychosomatik), Klinikum Saarbrücken gGmbH, Winterberg 1, 66119, Saarbrücken, Deutschland. whaeuser@klinikum-saarbruecken.de. · Deutsche Rheuma-Liga, Ellwangen, Deutschland. · Deutsche Fibromyalgie Vereinigung, Seckach, Deutschland. · AWMF-Institut für Medizinisches Wissensmanagement, Philipps-Universität, Marburg, Deutschland. · Schmerzmedizin, Klinik für Anästhesiologie, Universitätsmedizin Göttingen, Göttingen, Deutschland. ·Schmerz · Pubmed #28493222.

ABSTRACT: -- No abstract --

23 Editorial Criteria for fibromyalgia? What is fibromyalgia? Limitations to current concepts of fibromyalgia and fibromyalgia criteria. 2017

Wolfe, Frederick. ·National Data Bank for Rheumatic Diseases and University of Kansas School of Medicine, Wichita, KS, USA. fwolfe@arthritis-research.org. ·Clin Exp Rheumatol · Pubmed #28406762.

ABSTRACT: -- No abstract --

24 Editorial Fibromyalgia and central sensitization in chronic inflammatory joint diseases. 2017

Dougados, Maxime / Perrot, Serge. ·Service de rhumatologie, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France; INSERM U1153, Université Paris Descartes, 75006 Paris, France. Electronic address: maxime.dougados@aphp.fr. · Service de rhumatologie, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France; INSERM U987, Université Paris Descartes, 75006 Paris, France. ·Joint Bone Spine · Pubmed #28300697.

ABSTRACT: -- No abstract --

25 Editorial Fibromyalgia as a Contextual Factor Influencing Disease Activity Measurements in Spondyloarthritis and Psoriatic Arthritis. 2016

Leung, Ying Ying / Thumboo, Julian. ·Department of Rheumatology and Immunology, Singapore General Hospital; and Duke NUS Medical School, Singapore; katyccc@hotmail.com. · Department of Rheumatology and Immunology, Singapore General Hospital; Duke NUS Medical School; and Department of Medicine, Faculty of Medicine, National University of Singapore, Singapore. ·J Rheumatol · Pubmed #27803340.

ABSTRACT: -- No abstract --

Next